Skip to main content
Fig. 4 | BMC Neuroscience

Fig. 4

From: The effect of intracerebroventricular administration of orexin receptor type 2 antagonist on pentylenetetrazol-induced kindled seizures and anxiety in rats

Fig. 4

The effect of intracerebroventricular injection of TCS OX2 29 (1, 3.5 and 7 μg/rat) and valproate (26 µg/rat) on stage 4 duration in pentylenetetrazol-kindled rats. TCS OX2 29 at the dose of 7 μg/rat and valproate at the dose of 26 μg/rat decreased duration of 4th stage of seizures. Each bar represents mean ± SEM. *P < 0.05 compared to vehicle-treated rats. In each group n = 7

Back to article page